LabMedica

Download Mobile App
Recent News Expo
ADLM 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Finger Scanner for Malaria to Be Developed

By LabMedica International staff writers
Posted on 13 May 2010
An optomagnetic finger scanner is being developed for the diagnosis of malaria.

The noninvasive finger scanner will detect the presence of malarial hemozoin crystals in infected individuals. Hemozoin is the iron-containing pigment, which accumulates as cytoplasmic granules in malaria parasites and is a breakdown product of hemoglobin.

Light-emitting diodes, magnets, and electronic components available to do-it-yourself hobbyists will be used for constructing the instrument. In contrast to the test under development, current diagnosis of malaria is performed using invasive blood tests requiring sizable equipment.

On May 11, 2010, the DNA Medicine Institute (Cambridge, MA, USA) announced that it received a US $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation (Seattle, WA, USA) to develop the optomagnetic finger scanner. The project will be conducted by the DNA Medicine Institute's Eugene Y. Chan, M.D.

"I am pleased to have the opportunity to pursue an idea that pushes the envelope of malaria diagnosis. Malaria is a deadly disease that afflicts up to 500 million people each year. Millions die from it, including many young children in developing countries. My group is developing a tiny device that scans a finger, without any blood [sample], to allow anyone, anytime, and anywhere to check for malaria infection," said Dr. Chan.

Related Links:
DNA Medicine Institute
Bill & Melinda Gates Foundation


Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Steam Sterilizer
Hi Vac II Line

Latest Clinical Chem. News

Machine Learning Model Shows Promise for Improving Metanephrine Testing Accuracy
13 May 2010  |   Clinical Chem.

Common HbA1c Assay May Miss Diabetes in People with Sickle Cell Trait
13 May 2010  |   Clinical Chem.

Blood Protein Panel Predicts Timing of ALS Symptom Onset
13 May 2010  |   Clinical Chem.



PURITAN MEDICAL